A new vaccine that uses a persistent virus vector controlled SIV in 50 percent of tested monkeys
The Scientist
Most Recent
Does mitochondrial dysfunction lie at the heart of common, complex diseases like cancer and autism?
Clostridium difficile is evolving more robust toxicity, repeatedly attacking its victims, and driving the search for alternative therapies to fight the infection.
A promising gene therapy trial, derailed by cancerous side effects in a young patient, is set to reboot with the help of next generation gene-transfer vectors.
Are miRNAs useful for tracking and treating cardiovascular disease?
In discovering their shared ancestry, a distantly related animal geneticist and plant pathologist find a common thread in their work on immune receptors.
Understanding oncogenesis at the molecular level offers the prospect of tailoring treatments much more precisely for patients with advanced cases of this deadliest of skin cancers.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
